Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Chan-Young Ock, Bhumsuk Keam, Sehui Kim, et al.
British Journal of Cancer
|
July 30, 2024
Correction: Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
British Journal of Cancer
|
May 10, 2024
Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Oncoimmunology
|
August 21, 2019
High tumoral PD-L1 expression and low PD-1<sup>+</sup> or CD8<sup>+</sup> tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system
Sehui Kim, Soo Jeong Nam, Changhee Park, et al.
Cancer Immunology Research
|
September 5, 2024
Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression
Jaemoon Koh, Dongjoo Lee, Sehui Kim, et al.
Cancers
|
June 27, 2020
Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma
Jiwon Koh, Insoon Jang, Seongmin Choi, et al.
Histopathology
|
October 2, 2015
Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas
Dohee Kwon, Sehui Kim, Pil-Jong Kim, et al.
Oncoimmunology
|
May 4, 2016
EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3
Jaemoon Koh, Ji-Young Jang, Bhumsuk Keam, et al.
Oncoimmunology
|
June 15, 2018
Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system
Soo Jeong Nam, Sehui Kim, Dohee Kwon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 23, 2017
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis
Yu Jin Lim, Jaemoon Koh, Sehui Kim, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Chan-Young Ock, Bhumsuk Keam, Sehui Kim, et al.
British Journal of Cancer
|
July 30, 2024
Correction: Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
British Journal of Cancer
|
May 10, 2024
Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer
Hyein Jeong, Jaemoon Koh, Sehui Kim, et al.
Oncoimmunology
|
August 21, 2019
High tumoral PD-L1 expression and low PD-1<sup>+</sup> or CD8<sup>+</sup> tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system
Sehui Kim, Soo Jeong Nam, Changhee Park, et al.
Cancer Immunology Research
|
September 5, 2024
Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression
Jaemoon Koh, Dongjoo Lee, Sehui Kim, et al.
Cancers
|
June 27, 2020
Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma
Jiwon Koh, Insoon Jang, Seongmin Choi, et al.
Histopathology
|
October 2, 2015
Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas
Dohee Kwon, Sehui Kim, Pil-Jong Kim, et al.
Oncoimmunology
|
May 4, 2016
EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3
Jaemoon Koh, Ji-Young Jang, Bhumsuk Keam, et al.
Oncoimmunology
|
June 15, 2018
Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system
Soo Jeong Nam, Sehui Kim, Dohee Kwon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 23, 2017
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis
Yu Jin Lim, Jaemoon Koh, Sehui Kim, et al.
Page
of 8